As used in this article, the following terms have the following meanings: (a) âActâ means the California Stem Cell Research and Cures Act constituting this chapter, as amended by the California Stem Cell Research, Treatments, and Cures Initiative of 2020. (b) âBoardâ or âinstituteâ means the California Institute for Regenerative Medicine designated in accordance with subdivision (b) of Section 125291.120. (c) âCommitteeâ means the California Stem Cell Research and Cures Finance Committee created pursuant to subdivision (a) of Section 125291.40 and designated in accordance with subdivision (a) of Section 125291.120. (d) âFundâ means the California Stem Cell Research, Treatments, and Cures Fund of 2020 created pursuant to Section 125291.105. (e) âInterim debtâ means any interim loans pursuant to Sections 125291.140 and 125291.145, bond anticipation notes, or commercial paper notes issued to make deposits into the fund and that will be paid from the proceeds of bonds issued pursuant to this article.
‹ Prev All California sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.